QTREX Quantum

Develops monolithic cryogenic signal interconnects and processor interfaces for superconducting quantum computers. The designs combine conductors, RF dielectrics, shielding, thermal-management features and mechanical routing in one build, targeting lower thermal load, less congestion and simpler assembly inside dilution refrigerators.

Sells additive-electronics systems, proprietary inks, consumables, software, support services and customer-funded engineering programs; the Fabrica platform produces high-precision polymer and composite parts. Operations span headquarters, laboratories and manufacturing in Israel, with the United States identified as the dominant market for additive electronics and quantum infrastructure.

Retains a medical subsidiary with the FDA-cleared INSPIRA ART100 cardiopulmonary-bypass system and the HYLA blood-monitoring platform under development, while seeking a separate monetization. Quantum interconnect commercialization depends on collaborator qualification and deployment; acquired operations depend on integrated customer, supplier, personnel and systems transitions.